Novus Diagnostics is developing ground-breaking diagnostics technologies to provide rapid answers right at the patient’s bedside. Their first product, SepTec, will help tackle the global challenge of sepsis which kills more than 11 million people annually. Their technology platform combines novel electrochemical sensors, centrifugal microfluidics, and automated sample processing and analysis to diagnose and characterize a bloodstream infection within 15 minutes; enabling earlier lifesaving targeted treatment.